Difference between revisions of "Pilot Conformance Projects Under Development"
Jump to navigation
Jump to search
| (5 intermediate revisions by the same user not shown) | |||
| Line 32: | Line 32: | ||
:*[[Media:QIBA_CTVol_TumorVolumeChangeProfile-Conformance Testing_Supplement_2019051111.pdf | CT Conformance Testing Supplement, 2019-11-11]] | :*[[Media:QIBA_CTVol_TumorVolumeChangeProfile-Conformance Testing_Supplement_2019051111.pdf | CT Conformance Testing Supplement, 2019-11-11]] | ||
'''Report Template''' | '''Report Template''' | ||
| + | :*[[Media:QIBA_Conformance_Statement-Self-Attestation_CTvolAD_20191111-confirmed.pdf | CT Conformance Self - Attestation Document, 2019-11-11]] | ||
===FDG-PET: Solid Tumor SUV=== | ===FDG-PET: Solid Tumor SUV=== | ||
| Line 39: | Line 40: | ||
* [[Media:QIBA FDG PETCT _Conformance Testing_Checklist_20191111.pdf | QIBA FDG-PET/CT Conformance Testing Checklist, 2019-11-11]] | * [[Media:QIBA FDG PETCT _Conformance Testing_Checklist_20191111.pdf | QIBA FDG-PET/CT Conformance Testing Checklist, 2019-11-11]] | ||
'''Report Template''' | '''Report Template''' | ||
| + | * [[Media:QIBA_Conformance_Statement-Self-Attestation_FDG-PET_20191811_confirmed.pdf | QIBA FDG-PET/CT Conformance Self - Attestation Document, 2019-11-11]] | ||
===DWI MR: ADC of Lesions in Four Organs=== | ===DWI MR: ADC of Lesions in Four Organs=== | ||
| Line 48: | Line 50: | ||
**[[Media:QIBA DWI Profile _Conformance Testing_Supplement 2_20191111.pdf | QIBA DWI Conformance Testing Supplement #2, 2019-11-11]] | **[[Media:QIBA DWI Profile _Conformance Testing_Supplement 2_20191111.pdf | QIBA DWI Conformance Testing Supplement #2, 2019-11-11]] | ||
'''Report Template''' | '''Report Template''' | ||
| + | *[[Media:QIBA_Conformance_Statement-Self-Attestation_ADC_20191411_confirmed.pdf | QIBA DWI Conformance Self - Attestation Document, 2019-11-11]] | ||
Revision as of 19:25, 27 November 2019
QIBA Profile Conformance
{This content will eventually be available on the RSNA.org website.}
QIBA Profiles that are at least at the Consensus Stage are available to interested parties (clinical sites, CROs, equipment and/or software vendors) to demonstrate that all relevant actors of an institution or product conform to the respective QIBA Profile.
As shown in the following diagram, QIBA Profile conformance may be demonstrated via Self Attestation, or (when available) via a Certification service:
Before starting conformance testing, please Email QIBA
QIBA or Designee Testing of Conformance
CT Small Lung Nodule Volumetry for Screening
- CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18
- https://www.rsna.org/en/research/quantitative-imaging-biomarkers-alliance/qiba-conformance-certification-services
Self Attestation of Conformance
The following QIBA Profiles have reached the Consensus Stage or the Technically Confirmed Stage, and are thus appropriate for self-attestation conformance testing.
CT: Lung Tumor Volume (Advanced Disease)
Profile
Checklist
- CT Conformance Checklist (can also refer to Appendix C in the Profile document - pg 42)
- Assessment Procedures (refer to Section 4 in the Profile document - pg 30)
Report Template
FDG-PET: Solid Tumor SUV
Profile
Checklist
Report Template
DWI MR: ADC of Lesions in Four Organs
Profile
Checklist
Report Template